UK markets open in 5 hours 48 minutes
NIKKEI 225
38,189.39 -39.72 (-0.10%) HANG SENG
18,963.68 +425.88 (+2.30%) CRUDE OIL
78.01 -0.25 (-0.32%) GOLD FUTURES
2,368.30 -6.70 (-0.28%) DOW
39,512.84 +125.04 (+0.32%) Bitcoin GBP
49,091.54 +365.07 (+0.75%)
GILD Aug 2024 80.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:39PM EDT. Market open.
| Previous close | 15.65 |
| Open | 15.65 |
| Bid | 13.45 |
| Ask | 15.50 |
| Strike | 80.00 |
| Expiry date | 2024-08-16 |
| Day's range | 15.65 - 15.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 270 |
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
© 2024 Yahoo. All rights reserved.